MOUNT LAUREL, NJ (July 21, 2015) – PMC Group N.A., Inc. (“PMC”), a leader in the polymer additives industry, has demonstrated its ongoing commitment to

MEMPHIS, TN (January 5, 2016) – PMC Biogenix, a wholly owned subsidiary of PMC Group, announced plans to invest in the expansion of its manufacturing

MEMPHIS, TN (February 27, 2017) – PMC Biogenix, a wholly owned subsidiary of PMC Group, announced today that it has significantly expanded its production capacity

MEMPHIS, TN (May 9, 2017) – PMC Biogenix, Inc., a wholly owned subsidiary of PMC Group, as part of its continuing effort to strengthen and

CARROLLTON, KY (October 01, 2017) – PMC Organometallix, Inc., a wholly owned subsidiary of PMC Group, has expanded its distribution agreement with Safic-Alcan to include Eastern

MOUNT LAUREL, NJ (October 28, 2017) — PMC YM-Pharma Private Ltd., a subsidiary of PMC Group International, an independent arm of PMC Group Inc., announced

MOUNT LAUREL, NJ (December 4, 2017) — PMC Group France, a wholly owned subsidiary of PMC Group International Inc., which is an independent arm of

MEMPHIS, TN (December 5, 2017) — PMC Biogenix Inc. announces that effective January 1, 2018 or as contracts permit, prices for products sold under the

VERT-LE-PETIT, FRANCE (March 12, 2018) – Under the agreement, Polypeptide Therapeutic Solutions will use proprietary technology and research capabilities to offer contract research services from